{
  "trial_id": "NCT00367627",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "age",
      "label": "met",
      "evidence": "16 years old"
    },
    {
      "criterion": "diagnosis",
      "label": "met",
      "evidence": "myasthenia gravis, class IIa"
    },
    {
      "criterion": "symptoms",
      "label": "met",
      "evidence": "diplopia and weakness affecting upper extremities"
    },
    {
      "criterion": "treatment",
      "label": "met",
      "evidence": "acetylcholinesterase inhibitor treatment combined with immunosuppressants"
    }
  ],
  "exclusion": [
    {
      "criterion": "age",
      "label": "not_met",
      "evidence": "16 years old"
    },
    {
      "criterion": "stool test",
      "label": "met",
      "evidence": "positive for intestinal helminth"
    },
    {
      "criterion": "serious chronic illness",
      "label": "unknown",
      "evidence": "no information"
    }
  ],
  "notes": "Patient is a 16-year-old girl with myasthenia gravis, class IIa. She has symptoms of diplopia and weakness affecting her upper extremities. She is on acetylcholinesterase inhibitor treatment combined with immunosuppressants.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT00367627",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}